|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1991-7-30
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0007-1250
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
158
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:2054581-Adult,
pubmed-meshheading:2054581-Chlorpromazine,
pubmed-meshheading:2054581-Clopenthixol,
pubmed-meshheading:2054581-Clozapine,
pubmed-meshheading:2054581-Drug Therapy, Combination,
pubmed-meshheading:2054581-Humans,
pubmed-meshheading:2054581-Male,
pubmed-meshheading:2054581-Neuroleptic Malignant Syndrome,
pubmed-meshheading:2054581-Procyclidine,
pubmed-meshheading:2054581-Recurrence,
pubmed-meshheading:2054581-Schizophrenia,
pubmed-meshheading:2054581-Schizophrenic Psychology
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Clozapine-treated NMS.
|
|
pubmed:publicationType |
Letter,
Case Reports
|
